The second National Health Research Strategy Priority Framework webinar was held on the 25th of November 2022. This was a build-up session from the first one which was held only with the coalition members and other advocacy groups on the 19th of October 2022. This was aimed at increasing their understanding of NHRSPF. In this...
Our health systems endured a heavy – often invisible – cost during the COVID-19 pandemic. While the country was focused on the battle against this pandemic, long-fought gains against other infectious diseases were being rolled back. And none more so than with tuberculosis. The Lancet notes that South Africa has one of the highest tuberculosis (TB) burdens...
On 26th October 2022, the South African Health Technologies Coalition (SAHTAC), through its Regulatory Harmonisation work, supported the South African Health Products Regulatory Authority (SAHPRA) to host a webinar titled: SAHPRA unpacks global accolade upon receiving WHO Maturity Level 3. More than 337 people dialed into the webinar which was characterized by many questions and...
The National Health Research Strategy Priority Framework Workshop was held online as a Webinar on the 19th of October 2022. The main objective of the workshop was to conduct a retrospective explanatory analysis to examine the policy determination that is how the policy got to be on the agenda, how it was initiated and formulated,...
SAHTAC participated in the first joint World Health Summit co-hosted with WHO on 16 to 18 October in Berlin, Germany. The Summit brought together the most prominent names in global health from all sectors in all regions of the world. Held under the patronage of German Federal Chancellor Olaf Scholz, French President Emmanuel Macron, Senegal’s...
The Covid-19 pandemic not only exposed the weaknesses in our healthcare system but also revealed the deep-seated issues that remain prevalent with pharmaceutical companies responsible for developing lifesaving technology. The deep-seated issues pertaining to access to medical resources in third-world countries, where many countries are often left behind in the process of accessing lifesaving technology....
Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity NEW YORK, NY AND CAMBRIDGE, MA — MAY 18, 2022 — The nonprofit scientific research organization IAVI and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and...
While most African countries missed the global goal of fully vaccinating 10% of its population, other countries up north such as Germany and France are offering booster shots to their citizens. While this may mirror the disparity between the Global North and Global South, there is a worrying Covid-19 vaccine disproportion in Africa itself....
